1.Is Oxytocin Application for Autism Spectrum Disorder Evidence-Based?.
Seung Yup LEE ; Ah Rah LEE ; Ram HWANGBO ; Juhee HAN ; Minha HONG ; Geon Ho BAHN
Experimental Neurobiology 2015;24(4):312-324
Autism spectrum disorder (ASD) is characterized by persistent deficits within two core symptom domains: social communication and restricted, repetitive behaviors. Although numerous studies have reported psychopharmacological treatment outcomes for the core symptom domains of ASD, there are not enough studies on fundamental treatments based on the etiological pathology of ASD. Studies on candidate medications related to the pathogenesis of ASD, such as naltrexone and secretin, were conducted, but the results were inconclusive. Oxytocin has been identified as having an important role in maternal behavior and attachment, and it has been recognized as a key factor in the social developmental deficit seen in ASD. Genetic studies have also identified associations between ASD and the oxytocin pathway. As ASD has its onset in infancy, parents are willing to try even experimental or unapproved treatments in an effort to avoid missing the critical period for diagnosis and treatment, which can place their child in an irreversible state. While therapeutic application of oxytocin for ASD is in its early stages, we have concluded that oxytocin would be a promising therapeutic substance via a thorough literature review focusing on the following: the relationship between oxytocin and sociality; single nucleotide polymorphisms as a biological marker of ASD; and validity verification of oxytocin treatment in humans. We also reviewed materials related to the mechanism of oxytocin action that may support its potential application in treating ASD.
Autistic Disorder*
;
Child
;
Autism Spectrum Disorder*
;
Critical Period (Psychology)
;
Diagnosis
;
Humans
;
Maternal Behavior
;
Naltrexone
;
Oxytocin*
;
Parents
;
Pathology
;
Polymorphism, Single Nucleotide
;
Secretin
;
Social Change
;
Biomarkers
2.Psychosocial Pre-Transplant Assessment of Living Kidney Donors
Ah Rah LEE ; Myungjae BAIK ; Sang Min LEE ; Won Sub KANG ; Jin Kyung PARK
Korean Journal of Psychosomatic Medicine 2023;31(2):43-49
In Korea, the dependence on living donations is high due to the shortage of organs available for donation compared to the number of people waiting for transplants and the number of living organ donations continues to increase. In particular, the number of living-donor transplantations is high worldwide, highlighting the importance of pre-transplant psychosocial evaluation of living kidney donors. According to previous studies, when evaluating living organ donors before transplantation, it is crucial to determine whether the donor can give informed consent and be aware of the risks after surgery. Pre-transplant evaluation tests such as ELPAT living organ donor Psychological Assessment Tool (EPAT), Live Donor Assessment Tool (LDAT), Living Donation Expectancies Questionnaire (LDEQ), Minnesota Multiphasic Personality Inventory-2 questionnaire (MMPI-2) and Temperament and Character Inventory (TCI) are conducted for donors. After reviewing the literature on these pre-transplant psychosocial assessment tools, we will also look at legal considerations for living kidney donors in Korea and suggest an effective and essential pre-transplant screening evaluation method for living kidney transplant donors.
3.Advanced Pharmacotherapy Evidenced by Pathogenesis of Autism Spectrum Disorder.
Yeon Jung LEE ; Soo Hyun OH ; Chanmin PARK ; Minha HONG ; Ah Rah LEE ; Hee Jeong YOO ; Chan Young SHIN ; Keun Ah CHEON ; Geon Ho BAHN
Clinical Psychopharmacology and Neuroscience 2014;12(1):19-30
In clinical practice, pharmacological treatment is mostly focused on behavioral symptoms in everyday life. Nevertheless, persistent effort continues to develop medication for causal treatment. Recent changes in diagnostic criteria from Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision (DSM-IV-TR) to DSM-5 would affect not only diagnosing approaches, but also therapeutic approaches. Because previous pervasive developmental disorders have been integrated into a single entity, the autism spectrum disorder (ASD), we have to prepare for what medications are valuable for the ASD. In this article, we reviewed the following etiological treatment: acetylcholine and glutamate related medicine; amino acid medicine such as secretin, endogenous opioid, and oxytocin; complementary and alternative medicine such as chelating agents, vitamins, and omega-3; promising drugs related to the scope of pharmacogenetics currently under study.
Acetylcholine
;
Behavioral Symptoms
;
Chelating Agents
;
Child
;
Autism Spectrum Disorder*
;
Complementary Therapies
;
Diagnostic and Statistical Manual of Mental Disorders
;
Drug Therapy*
;
Glutamic Acid
;
Oxytocin
;
Pharmacogenetics
;
Secretin
;
Vitamins
4.Can Pre-Transplant Psychometric Testing Predict Tacrolimus Intrapatient Variability After Living Kidney Transplantation?
Ah Rah LEE ; Sang Min LEE ; Won Sub KANG ; Ah Rang CHO ; Jong Woo KIM ; Jin Kyung PARK
Psychiatry Investigation 2024;21(7):718-725
Objective:
Tacrolimus intrapatient variability (Tac IPV) has been considered a marker for post-graft risk. We investigated pre-transplant psychometric testing to predict Tac IPV after living kidney transplantation.
Methods:
Minnesota Multiphasic Personality Inventory-2 (MMPI-2) examined during pre-transplant evaluation by 102 recipients were analyzed. Subjects were divided into two groups, low IPV (L-IPV) and high IPV (H-IPV), by cutoffs of Tac IPV: median of 24 and value of 30. T-scores of MMPI-2 scales were used to analyze difference between L-IPV and H-IPV using independent t-tests. Stepwise multiple logistic regression was used to test whether MMPI-2 scales affected Tac IPV. Confusion matrix of logistic regression was used to explain statistical power. Cutoff values of significant scales for H-IPV were analyzed by constructing receiver operating characteristic curves.
Results:
Hysteria (Hy) and depression (D) scale scores and Tac IPV were associated in IPV 24 (odds ratio [OR]: 1.08, p<0.01 for Hy; OR: 0.93, p<0.01 for D) and IPV 30 models (OR: 1.09, p<0.01 for Hy; OR: 0.92, p<0.01 for D). Paranoia (Pa) scale scores were associated with Tac IPV in IPV 24 model (OR=1.10, p<0.01) and were significantly higher in H-IPV 24 (p<0.01). F1 scores of confusion matrix in IPV 24 and 30 models were 0.70 and 0.71, respectively. Cutoffs of Hy, D, and Pa scales were 51, 57, and 47, respectively.
Conclusion
MMPI-2 profile is suggested as a predictor for high Tac IPV after living kidney transplantation.
5.Third trimester listeriosis in twin pregnant woman with multiple organ dysfunction syndrome and combined endocarditis: A case report.
Eun Jung SOH ; Tae Gyu AHN ; Ae Rah HAN ; Hyang Ah LEE ; Jong Yun HWANG ; Hye Sung WON ; Dong Heon LEE ; Jun Sik CHO
Korean Journal of Obstetrics and Gynecology 2008;51(5):568-573
Human listeriosis is a relatively rare but serious disease with mortality rate 20~40%. Listeria monocytogenes affects patients with decreased cell mediated immunity such as the elderly, transplant recipients, cancer patients, renal failure, diabetes, HIV, pregnant women and unborn child, neonate. We experienced a case of listeriosis in twin pregnant woman at 35th weeks without preterm labor. The pregnant woman present sepsis with fever at first time. Sepsis progress to MODS (multiple organ dysfunction syndrome) and combined endocarditis. We reported it with brief of literatures.
Aged
;
Child
;
Endocarditis
;
Female
;
Fever
;
HIV
;
Humans
;
Immunity, Cellular
;
Infant, Newborn
;
Listeria
;
Listeria monocytogenes
;
Listeriosis
;
Multiple Organ Failure
;
Obstetric Labor, Premature
;
Pregnancy
;
Pregnancy Trimester, Third
;
Pregnancy, Twin
;
Pregnant Women
;
Renal Insufficiency
;
Sepsis
6.Stigma Experience and Mental Health of Vulnerable Groups:Focusing on the COVID-19 Period
Sung Moon CHOI ; Jong-Woo PAIK ; Myung Jae PAIK ; Jin Hee HYUN ; Sung Eun YOU ; Ah Rah LEE ; Sang Min LEE
Journal of Korean Neuropsychiatric Association 2024;63(4):225-236
Objectives:
This study explored the stigma and mental health challenges that vulnerable populations faced during COVID-19 using in-depth interviews with 32 participants.
Methods:
A generic qualitative methodology was employed, with data collected via face-to-face and Zoom interviews conducted from March to August 2021.
Results:
Two major themes emerged: the nature of stigmatization and mental health impacts.The participants reported increased exposure to personal information, worsening institutional stigmatization, and routine social exclusion, leading to internalized stigma. They experienced extreme fear, anxiety, depression, hopelessness, suicidal thoughts, and declining physical health.
Conclusion
The results underscore the necessity of a comprehensive mental health support system that integrates psychological interventions, stigma prevention education, anti-stigma initiatives, and customized policies. Future research should investigate the prolonged impact of pandemic-induced stigma and devise effective strategies for support and intervention.
7.Stigma Experience and Mental Health of Vulnerable Groups:Focusing on the COVID-19 Period
Sung Moon CHOI ; Jong-Woo PAIK ; Myung Jae PAIK ; Jin Hee HYUN ; Sung Eun YOU ; Ah Rah LEE ; Sang Min LEE
Journal of Korean Neuropsychiatric Association 2024;63(4):225-236
Objectives:
This study explored the stigma and mental health challenges that vulnerable populations faced during COVID-19 using in-depth interviews with 32 participants.
Methods:
A generic qualitative methodology was employed, with data collected via face-to-face and Zoom interviews conducted from March to August 2021.
Results:
Two major themes emerged: the nature of stigmatization and mental health impacts.The participants reported increased exposure to personal information, worsening institutional stigmatization, and routine social exclusion, leading to internalized stigma. They experienced extreme fear, anxiety, depression, hopelessness, suicidal thoughts, and declining physical health.
Conclusion
The results underscore the necessity of a comprehensive mental health support system that integrates psychological interventions, stigma prevention education, anti-stigma initiatives, and customized policies. Future research should investigate the prolonged impact of pandemic-induced stigma and devise effective strategies for support and intervention.
8.Stigma Experience and Mental Health of Vulnerable Groups:Focusing on the COVID-19 Period
Sung Moon CHOI ; Jong-Woo PAIK ; Myung Jae PAIK ; Jin Hee HYUN ; Sung Eun YOU ; Ah Rah LEE ; Sang Min LEE
Journal of Korean Neuropsychiatric Association 2024;63(4):225-236
Objectives:
This study explored the stigma and mental health challenges that vulnerable populations faced during COVID-19 using in-depth interviews with 32 participants.
Methods:
A generic qualitative methodology was employed, with data collected via face-to-face and Zoom interviews conducted from March to August 2021.
Results:
Two major themes emerged: the nature of stigmatization and mental health impacts.The participants reported increased exposure to personal information, worsening institutional stigmatization, and routine social exclusion, leading to internalized stigma. They experienced extreme fear, anxiety, depression, hopelessness, suicidal thoughts, and declining physical health.
Conclusion
The results underscore the necessity of a comprehensive mental health support system that integrates psychological interventions, stigma prevention education, anti-stigma initiatives, and customized policies. Future research should investigate the prolonged impact of pandemic-induced stigma and devise effective strategies for support and intervention.
9.Stigma Experience and Mental Health of Vulnerable Groups:Focusing on the COVID-19 Period
Sung Moon CHOI ; Jong-Woo PAIK ; Myung Jae PAIK ; Jin Hee HYUN ; Sung Eun YOU ; Ah Rah LEE ; Sang Min LEE
Journal of Korean Neuropsychiatric Association 2024;63(4):225-236
Objectives:
This study explored the stigma and mental health challenges that vulnerable populations faced during COVID-19 using in-depth interviews with 32 participants.
Methods:
A generic qualitative methodology was employed, with data collected via face-to-face and Zoom interviews conducted from March to August 2021.
Results:
Two major themes emerged: the nature of stigmatization and mental health impacts.The participants reported increased exposure to personal information, worsening institutional stigmatization, and routine social exclusion, leading to internalized stigma. They experienced extreme fear, anxiety, depression, hopelessness, suicidal thoughts, and declining physical health.
Conclusion
The results underscore the necessity of a comprehensive mental health support system that integrates psychological interventions, stigma prevention education, anti-stigma initiatives, and customized policies. Future research should investigate the prolonged impact of pandemic-induced stigma and devise effective strategies for support and intervention.
10.Effects of Integrated Psychological Therapy for Schizophrenic Patients.
Man Hong LEE ; Hee Sang LEE ; Hyun Sang CHO ; Myoung Ho HYUN ; Suk Kyoon AN ; Sang Woo YOO ; Seung Jin HAN ; Jee Hwan PARK ; Yong Ho HYUN ; Min Seong KOO ; Seok Han SOHN ; Se Joo KIM ; Hyun Ju LEE ; So Rah PARK ; Seon Mi SONG ; Hye Ry AN ; Jung Ah CHOI ; Kee NAMKOONG ; Kae Joon YOO
Journal of Korean Neuropsychiatric Association 1998;37(6):1074-1086
OBJECTIVES: This study, as a preliminary one attempting to develop the Korean version of Integrated Therapy for the rehabilitation of schizophrenic patients, was designed to investigate the results of Integrated Psychological Therapy(IPT) and review the problems during the program application. METHODS: Cognitive Differentiation Scale, Problem-Solving Scale, and PANSS(Positive And Negative Syndrome Scale) were administered to schizophrenic inpatients before and after IPT incorporating cognitive differentiation, social perception, verbal communication, social skill and interpersonal problem-solving skill subprograms. The therapy groups were offered activities three times per week during the 12-week program. The control groups were attention-placebo groups for control ling factors such as group interaction and social attention, and were offered psychoeducation. RESULTS: The 12-week IPT groups, compared with the control groups, demonstrated significant improvements in the general psychopathology and the total symptoms of PANSS, but did not in cognitive functions and problem-solving skill. Significant improvements in cognitive functions were found only after cognitive differentiation subprogram and social skill subprogram had limited effects on social skills. But within 12-week IPT groups significant improvements in the positive symptoms, negative symptoms and general psychopathology were found. CONCLUSION: These findings support some effectiveness of IPT, but do not address the unique contribution by cognitive components. Applied to schizophrenic patients in this country, this modality had the problems such as differences in sociocultural and lingual background, duration of treatment, homogeneity in the level of the functioning among group members, management of emotions in activities, and the therapists' skill in the training of cognitive components. So the modification of this modality will be required.
Humans
;
Inpatients
;
Psychopathology
;
Rehabilitation
;
Schizophrenia
;
Social Perception